iNVESTOR CALENDAR 2025

1 January - 18 February Silent Period  
9-10 January Octavian Seminar

Davos

14 -15 January JP Morgan Healthcare Conference San Francisco
19 February Full-Year 2024 Results Webcast
20-21 February Roadshow with ZKB Zurich and Geneva
4 March Morgan Stanley European Healthcare Conference London
5 March UBS European Healthcare Conference London
6 March  Roadshow with Bernstein Paris
26 March IDS 2025 (International Dental Show) Cologne
10 April Annual General Meeting of Shareholders Basel
1-29 April Silent Period  
30 April First quarter 2025 results Webcast
6 - 7 May Berenberg Roadshow  London
8 – 9 May Kepler Cheuvreux Roadshow Amsterdam
12 May Bernstein Roadshow Madrid 
13 May BofA Global Healthcare Conference Las Vegas 
20 May  Equita Roadshow Dublin
28 – 29 May Stifel Jaws and Paws Conference New York
4 – 5 Jun Jefferies Global Healthcare Conference New York
17 June Citi European Healthcare Conference London
19 June J.P. Morgan European Healthcare Forum London
1 July-12 August Silent Period  
13 August Second quarter 2025 results Webcast
14 -15 August Swiss Roadshow Zurich & Geneva
3 September Wells Fargo Heathcare Conference Boston
4 September Goldman Sachs Medtech Conference London
8 September Morgan Stanley Healthcare Conference New York
9–10 September Canada Roadshow Toronto & Montreal
23 September UBS Conference Wolfsberg
25 September Bank of America Healthcare Conference London
30 September-28 October Silent Period  
29 October Third quarter 2025 results Webcast
4 -5 November  J.P. Morgan UK Roadshow London
5 November ZKB Swiss Equity Conference Zurich
6 November ODDO Germany Roadshow Frankfurt
25 November Capital Markets Day Basel & Webcast
2 December Citi Global HC Conference  Miami
3 December  Evercore HC Conference Miami
1 Jan - 17 Fab 2026 Quiet period  
18 February 2026 Full-Year 2025 Results  Webcast

* Quiet Period: The period beginning on the quarter-end date when financial performance for the period can be measured internally and ending at the time of the earnings release for that quarter, Straumann Group Management or Investor Relations do not engage in any formal or informal business discussions with analysts or investors.